CTSH vs LDOS
Cognizant and Leidos, both Technology
Cognizant is the larger company at $21B against $13B. On trailing earnings LDOS is the cheaper of the two at a P/E of 12.6 against 13.5, a gap that is only a bargain if the two are growing at similar rates. Over the past year CTSH returned -11% against -20% for LDOS. Ryufin's sector-relative Smart Score puts LDOS ahead, 8/10 against 7/10.
| Figure | CTSH | LDOS |
|---|---|---|
| Last close | $62.06 | $137 |
| Market cap | $21B | $13B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 13.5 | 12.6 |
| Dividend yield | 2.0% | 1.2% |
| 1-year return | -11% | -20% |
| 5-year return | -8.3% | +38% |
| Ryufin Smart Scoresector-relative, 1–10 | 7/10 | 8/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Cognizant
Revenue of $5.4B in Q1 2026, net income $662M. Its largest reported line is Health Sciences, 32% of the disclosed total.
Leidos
Revenue of $4.4B in Q1 2026, net income $328M. Its largest reported line is Intelligence And Digital, 49% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.